Compare MEDP & YUMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | YUMC |
|---|---|---|
| Founded | 1992 | 1987 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6B | 14.8B |
| IPO Year | 2016 | 2016 |
| Metric | MEDP | YUMC |
|---|---|---|
| Price | $616.76 | $41.68 |
| Analyst Decision | Hold | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $473.17 | N/A |
| AVG Volume (30 Days) | 175.5K | ★ 1.4M |
| Earning Date | 04-22-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.38% |
| EPS Growth | ★ 20.98 | 7.73 |
| EPS | ★ 8.53 | 1.57 |
| Revenue | N/A | ★ $11,797,000,000.00 |
| Revenue This Year | $13.19 | $9.42 |
| Revenue Next Year | $7.75 | $5.86 |
| P/E Ratio | $72.74 | ★ $26.55 |
| Revenue Growth | N/A | ★ 4.37 |
| 52 Week Low | $373.00 | $40.15 |
| 52 Week High | $677.90 | $58.39 |
| Indicator | MEDP | YUMC |
|---|---|---|
| Relative Strength Index (RSI) | 63.36 | 29.86 |
| Support Level | $561.82 | $40.15 |
| Resistance Level | $629.30 | $49.31 |
| Average True Range (ATR) | 13.67 | 0.87 |
| MACD | -0.97 | -0.44 |
| Stochastic Oscillator | 90.48 | 0.77 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Yum China is the largest restaurant operator in China, with over 18,000 locations and USD 12 billion in systemwide sales as of 2025. It generates revenue primarily from its own restaurants and franchise fees. While KFC and Pizza Hut are its flagship brands, Yum China's portfolio also includes Little Sheep, Taco Bell, Huang Ji Huang, and Lavazza.As a trademark licensee of Yum Brands, Yum China pays 3% of KFC and Pizza Hut's systemwide sales to its former parent, from which it spun off in 2016. However, even before the separation, Yum China was granted substantial autonomy, giving its Chinese leadership decision-making authority over menu, supply chain, and marketing—an unusual practice for Western chains at the time.